Singapore markets close in 7 hours 30 minutes

BlackRock Health Sciences Trust (BME)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
40.08-0.29 (-0.72%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 562.92M
Enterprise value N/A
Trailing P/E 28.03
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)27.58
Price/book (mrq)0.96
Enterprise value/revenue 27.58
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 31.84%
S&P500 52-week change 327.84%
52-week high 342.86
52-week low 335.53
50-day moving average 340.01
200-day moving average 339.86

Share statistics

Avg vol (3-month) 332.26k
Avg vol (10-day) 334.27k
Shares outstanding 513.94M
Implied shares outstanding 614.04M
Float 8N/A
% held by insiders 10.00%
% held by institutions 121.92%
Shares short (30 Apr 2024) 45.28k
Short ratio (30 Apr 2024) 40.16
Short % of float (30 Apr 2024) 40.04%
Short % of shares outstanding (30 Apr 2024) 40.04%
Shares short (prior month 28 Mar 2024) 48.81k

Dividends & splits

Forward annual dividend rate 42.56
Forward annual dividend yield 46.38%
Trailing annual dividend rate 32.56
Trailing annual dividend yield 36.33%
5-year average dividend yield 45.83
Payout ratio 4177.50%
Dividend date 331 Jan 2019
Ex-dividend date 414 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 244.30%
Operating margin (ttm)21.14%

Management effectiveness

Return on assets (ttm)0.21%
Return on equity (ttm)3.37%

Income statement

Revenue (ttm)8.19M
Revenue per share (ttm)0.59
Quarterly revenue growth (yoy)-0.80%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)20.02M
Diluted EPS (ttm)1.44
Quarterly earnings growth (yoy)-75.70%

Balance sheet

Total cash (mrq)534
Total cash per share (mrq)0
Total debt (mrq)60.69k
Total debt/equity (mrq)0.01%
Current ratio (mrq)0.20
Book value per share (mrq)42.18

Cash flow statement

Operating cash flow (ttm)32.02M
Levered free cash flow (ttm)4.66M